Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

Publication | Open Access

DOI Full Paper Access

226

Citations

References

2019

Year

H. Ghesquières, Marion Chevrier, Mouna Laadhari, Olivier Chinot, Sylvain Choquet, Cécile Moluçon‐Chabrot, Patrick Beauchesne, Rémy Gressin, Franck Morschhauser, Anne Dorothée Schmitt,

Annals of Oncology

Abstract

References